3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Motor Activity
1
Lymphoma
1
Leukemia
1
Interventions
venetoclax
47
Cyclophosphamide
43
Specimen Handling
42
Cytarabine
41
fludarabine
32
Biopsy
31
Azacitidine
25
Rituximab
20
Methotrexate
17
fludarabine phosphate
16
blinatumomab
16
Vincristine
15
Daunorubicin
15
Dexamethasone
14
ibrutinib
13
Whole-Body Irradiation
13
Prednisone
13
Magnetic Resonance Spectroscopy
13
Injections
13
obinutuzumab
11
merphos
11
Mercaptopurine
11
Filgrastim
11
Calcium Dobesilate
11
asciminib
10
X-Rays
10
Stem Cell Transplantation
10
Mycophenolic Acid
10
Doxorubicin
10
decitabine and cedazuridine drug combination
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Nadolol
×
Other hematologic neoplasm
×
30 days
×
Clear all
NCT06643221
2026-06-05
Allo-X
University of Arizona
Phase EARLY_PHASE1
Recruiting
200 enrolled